Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines.
about
Activity of soluble OX40 ligand is enhanced by oligomerization and cell surface immobilizationGlucocorticoid-induced tumor necrosis factor receptor family-related protein triggering enhances HIV-specific CD4+ T cell cytokine secretion and protects HIV-specific CD4+ T cells from apoptosisPrinciples of antibody-mediated TNF receptor activationLatent Membrane Protein 1 as a molecular adjuvant for single-cycle lentiviral vaccinesFrom plasmids to protection: a review of DNA vaccines against infectious diseasesEnhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands.Nanoparticle-delivered multimeric soluble CD40L DNA combined with Toll-Like Receptor agonists as a treatment for melanoma.Adjuvantive effects of anti-4-1BB agonist Ab and 4-1BBL DNA for a HIV-1 Gag DNA vaccine: different effects on cellular and humoral immunity.Enhancement of DNA Vaccine-induced Immune Responses by Influenza Virus NP Genebeta-Glucan oligosaccharide enhances CD8(+) T cells immune response induced by a DNA vaccine encoding hepatitis B virus core antigen.CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challengeConsiderations for combined immune checkpoint modulation and radiation treatment.Multifunctional CD40L: pro- and anti-neoplastic activity.DNA/MVA Vaccines for HIV/AIDSCD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV-1-infected and HIV-1-uninfected individualsImmunotargeting with CD154 (CD40 ligand) enhances DNA vaccine responses in ducks.EBV LMP1, a viral mimic of CD40, activates dendritic cells and functions as a molecular adjuvant when incorporated into an HIV vaccine.HIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunityMacaque multimeric soluble CD40 ligand and GITR ligand constructs are immunostimulatory molecules in vitroDNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titersSoluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine.Soluble CD40 ligand contributes to dendritic cell-mediated T-cell dysfunction in HIV-1 infection.Technologies for enhanced efficacy of DNA vaccines.A multi-trimeric fusion of CD40L and gp100 tumor antigen activates dendritic cells and enhances survival in a B16-F10 melanoma DNA vaccine modelPharmacological modulation of GITRL/GITR system: therapeutic perspectives.Human immunodeficiency virus type 1 vaccine development: recent advances in the cytotoxic T-lymphocyte platform "spotty business".Human glucocorticoid-induced TNF receptor ligand regulates its signaling activity through multiple oligomerization states.CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cellsDesign of CD40 agonists and their use in growing B cells for cancer immunotherapy.Vaccination with a fusion protein that introduces HIV-1 gag antigen into a multitrimer CD40L construct results in enhanced CD8+ T cell responses and protection from viral challenge by vaccinia-gag.Design of vaccine adjuvants incorporating TNF superfamily ligands and TNF superfamily molecular mimics.Modulation of HIV-1 immunity by adjuvants.Tumor necrosis factor receptor/tumor necrosis factor family members in antiviral CD8 T-cell immunity.T-cell intrinsic effects of GITR and 4-1BB during viral infection and cancer immunotherapy.Regulation of PI-3-Kinase and Akt Signaling in T Lymphocytes and Other Cells by TNFR Family MoleculesThe contextual role of TNFR family members in CD8(+) T-cell control of viral infections.Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2.Binding Studies of TNF Receptor Superfamily (TNFRSF) Receptors on Intact Cells.Recombinant monomeric CD40 ligand for delivering polymer particles to dendritic cells.Oligomerization is required for the activity of recombinant soluble LOX-1.
P2860
Q24318411-9EC9CA90-5CD4-4A52-A0EB-B29E46B1E931Q24613773-5FCB059B-B4A3-4E8B-8847-A8F4C34775AEQ26796270-060000A1-957A-428E-8E07-EBEB53AF51A6Q27497985-AA2ABFFF-23A6-4F92-A088-84E3C6295586Q28250092-D56531D2-07C0-4C74-8146-26E7070C094FQ33489847-75C90981-EA42-41DA-AE59-2F4E96B10EFCQ33509292-364DAE8A-9636-4519-BA76-C82663F7E154Q33624219-9685CC05-8859-4190-9851-7A53862ED7DCQ33631967-5E5D26E0-5077-4F1C-A0CE-0C99F21EAB9CQ33960217-42E025F6-4653-4811-BE41-02EC882403E5Q34059531-DD050808-476B-42EC-AE7D-D7F4C8120915Q34174871-A5CA0765-E71C-427C-8032-D4461B80D9E0Q34422566-9C443993-BBD9-419E-80CE-8EF822C142CBQ34492802-EC699CAE-C41E-4F84-A1D0-F7077F5BFB12Q34692141-1BCA86F5-2243-4083-8FEB-476CEC6D0957Q34975067-D0140E1F-A001-4E0D-ADAB-C11A4C31B34AQ35096745-1B59379E-0EE5-45F1-8CA3-1DD2F7A79DB9Q35108680-CC82460F-813A-4AB9-A568-EE071EA87E83Q35160688-1614C6E1-45E7-43D6-BE17-30619C3319C3Q35640984-5096BCBC-3EFD-479A-8A83-3ABF5AAA992DQ35661163-4FD0A2EF-DFC5-4BCF-9DBC-44629D456917Q35772650-A0748437-8834-407F-9049-2D417EB9FB66Q35802958-5C1BC0B8-1431-472F-B7D2-F92997B3C53AQ36037271-D7F07B47-0298-4786-8962-EF0153903915Q36147260-E09DBB69-F20A-442C-9E7F-924579BC2B19Q36498186-99EEDFB5-F3BC-48B5-A1EF-15EB1305D606Q36535410-0F457D35-35F1-4BD7-8EBC-5730E01E4622Q36601966-24703F1E-A924-4CED-A0D6-0DFA6D4CB8ACQ37273700-8100BCFF-BC2E-402A-B228-48490CC8D7B7Q37547365-BF9E305F-ACD5-463C-9D81-5751733F3401Q37668114-50198C79-C770-44ED-993F-834F453A28D3Q37698564-5F26FDFF-3666-45DF-ADC2-7DED797AD64BQ37727208-2790ACFB-8812-4FF9-889B-91655F412C61Q37948129-D9AC2706-CB4B-4AA0-B6C3-497CBA684110Q38113962-715DB664-A39C-4EAE-8043-24884E8A8BFEQ38129083-B9E0F447-0E0E-44AC-9A47-BDFDBD492BBBQ38659118-B5D1F691-6AEC-4BD4-A615-5C48E2087B7BQ38771001-86705614-4501-46B5-A264-74C07E56C219Q39549087-A3566A4C-5594-4A1B-8FD4-9A26F97AA3D4Q42152313-133C6007-DB3A-4170-BE77-961DA6C8E3C0
P2860
Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Multimeric Soluble CD40 Ligand ...... odeficiency Virus DNA Vaccines
@nl
Multimeric soluble CD40 ligand ...... deficiency virus DNA vaccines.
@ast
Multimeric soluble CD40 ligand ...... deficiency virus DNA vaccines.
@en
type
label
Multimeric Soluble CD40 Ligand ...... odeficiency Virus DNA Vaccines
@nl
Multimeric soluble CD40 ligand ...... deficiency virus DNA vaccines.
@ast
Multimeric soluble CD40 ligand ...... deficiency virus DNA vaccines.
@en
prefLabel
Multimeric Soluble CD40 Ligand ...... odeficiency Virus DNA Vaccines
@nl
Multimeric soluble CD40 ligand ...... deficiency virus DNA vaccines.
@ast
Multimeric soluble CD40 ligand ...... deficiency virus DNA vaccines.
@en
P2093
P2860
P1433
P1476
Multimeric soluble CD40 ligand ...... odeficiency virus DNA vaccines
@en
P2093
Celsa A Spina
Geoffrey W Stone
Kristin Kee
Suzanne Barzee
Victoria Snarsky
Xiao-Fang Yu
P2860
P304
P356
10.1128/JVI.80.4.1762-1772.2006
P577
2006-02-01T00:00:00Z